Skip to main content
. 2015 Jun 29;112(28):8632–8637. doi: 10.1073/pnas.1510929112

Fig. S5.

Fig. S5.

The endogenous FBXO31–MDM2 interaction is lost following treatment of IMR90 cells with the ATM inhibitor KU-55933. Coimmunoprecipitation analysis monitoring the endogenous FBXO31–MDM2 interaction in IMR90 cells treated in the presence or absence of camptothecin or KU-55933. Extracts were immunoprecipitated with an FBXO31 or MDM2 antibody.